Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma
Clinical trial NCT03535259 · COMPLETED
Trial details
- NCT number
- NCT03535259
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-08
- Primary completion
- 2020-01-31
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.